// App-Quantinova.ai

: Efficacy and Safety of Abrocitinib According to Geographies

Researchers

Presenter

  • Andrew F. Alexis

Principal Investigators

  • Zakiya P. Rice

  • Kenji Kabashima

  • Paula C. Luna

  • Jacob P. Thyssen

  • Magdalena Trzeciak

  • Pinaki Biswas

  • Gary L. Chan

  • Erman Güler

  • Mark Levenberg

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Dermatology Associates of Georgia, Atlanta, GA, USA

  • Kyoto University, Kyoto, Japan

  • Hospital Durand, Buenos Aires, Argentina

  • Herlev Hospital, University of Copenhagen, Herlev, Denmark

  • Medical University of Gdansk, Gdansk, Poland

  • Pfizer Inc, New York, NY

  • Pfizer, Groton, CT

  • Pfizer Inc., Istanbul, Turkey

Locations

  • United States

  • Japan

  • Argentina

  • United Kingdom

  • Poland

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved